Solid oral formulations and crystalline forms of an inhibitor of apoptosis protein

• 收藏
• 分享

专利权人:

Novartis AG

发明人:

THAKUR, Jeewan,YANG, Dong,FENG, Lili

申请号：

AU2014213533

公开号：

AU2014213533A1

申请日:

2014.08.14

申请国别(地区):

AU

年份:

2014

代理人:

摘要：

#$%^&*AU2014213533A120140904.pdf#####H: dar Intenvoven NRPortbl DCC DAR 6601609.Ldoc-13/08/2014 ABSTRACT The present disclosure relates to crystalline form of (S)-N-((S)-1-cyclohexyl-2-{(S)2-[4-(4-fluoro-benzoyl)-thiazol-2-yl]-pyrrolidin-1 -yl)-2-oxo-ethyl)-2-methylaminopropionamide, salts and hydrates thereof. This disclosure also relates to solid oral formulation of (S)-N-((S)-1-cyclohexyl-2-{(S)-2-[4-(4-fluoro-benzoyl)-thiazol-2-yl]pyrrolidin-1 -yl}-2-oxo-ethyl)-2-methylamino-propionamide, pharmaceutically acceptable salts, solvates (including hydrates) thereof, as well as methods of treatment using the same.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/